A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and int
- This topic has 0 replies, 1 voice, and was last updated 12 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.
http://www.nature.com/bjc/journal/v105/n9/full/bjc2011376a.html
Tables and Data from the report –
http://www.nature.com/bjc/journal/v105/n9/fig_tab/bjc2011376t1.html
http://www.nature.com/bjc/journal/v105/n9/fig_tab/bjc2011376ft.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.